While considered an essential component for malaria elimination [45–47], the safety of PQ must be given careful consideration given the risk of hemolysis in G6PD-deficient individuals, who may be at even more risk in a large-scale elimination campaign that does not allow for close, individual follow-up [48]. The gene discussed is G6PD; the disease is malaria.